A Comparison of Efficacy and Safety of Two Lipid-Based Lubricant Eye Drops for the Management of Evaporative Dry Eye Disease

被引:14
|
作者
Jerkins, Gary [1 ]
Greiner, Jack, V [2 ,3 ]
Tong, Louis [4 ,5 ,6 ]
Tan, Jacqueline [7 ]
Tauber, Joseph [8 ]
Mearza, Ali [9 ,10 ]
Srinivasan, Sruthi [11 ]
机构
[1] Adv Vis Res LLC, Nashville, TN 37205 USA
[2] Clin & & Res Boston, Boston, MA USA
[3] Harvard Med Sch, Dept Ophthalmol, Boston, MA 02115 USA
[4] Natl Univ Singapore, Singapore Natl Eye Ctr, Singapore, Singapore
[5] Singapore Eye Res Inst, Singapore, Singapore
[6] Duke Natl Univ, Singapore Med Sch, Singapore, Singapore
[7] Univ New South Wales, Sydney, NSW, Australia
[8] Tauber Eye Ctr, Kansas City, MO USA
[9] Imperial Coll Healthcare NHS Trust, London, England
[10] Ophthalm Consultants London, London, England
[11] Alcon Res LLC, Johns Creek, GA USA
来源
CLINICAL OPHTHALMOLOGY | 2020年 / 14卷
关键词
dry eye; lipid-deficient; evaporative dry eye; lubricant eye drops; non-inferiority; ARTIFICIAL TEARS; MULTICENTER; DEFICIENT; EMULSION; LAYER;
D O I
10.2147/OPTH.S256351
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: The aim of this study was to compare the efficacy of two lipid-based lubricant eye drops in patients with lipid-deficient dry eye. Methods: This Phase IV, multicenter, prospective, double-masked study enrolled adults (aged >= 18 years) who had a tear film breakup time (TFBUT) of <= 15 seconds(s), and unanesthetized Schirmer I test of >= 3 mm to <= 12 mm in at least one eye, at both screening and baseline visits. Eligible patients (n=231) were randomized (1:1) and received either Systane (R) Balance (SYSB; n=117) or Refresh (R) Optive Advanced (RFO-Ad, n=114), four-times a day, for 35 days. The primary endpoint was non-inferiority for change from baseline in TFBUT at Day 35 (noninferiority was established if the lower limit of the 95% confidence interval (CI) for the difference between the treatment groups was > -1.0 s); secondary endpoints (test of superiority) were change in TFBUTand global ocular discomfort visual analog scale (VAS) score at Day 35. Other endpoints included the impact of dry eye on everyday life (IDEEL) treatment satisfaction scores (inconvenience and effectiveness) and safety. Results: At Day 35, themean change from baseline in TFBUTwas 0.998 s in the SYSB and 0.868 s in the RFO-Ad groups with a treatment difference: 0.130 s; (95% CI -0.34, 0.60; P<0.0001) demonstrating non-inferiority of SYSB to RFO-Ad. The global ocular discomfort VAS scores improved in both groups, with a mean change from baseline of -9.7 and -8.8 in SYSB and RFOAd groups (treatment difference -0.8; P=0.62), respectively. No meaningful difference was observed in IDEEL treatment effectiveness and treatment inconvenience scores between SYSB vs RFO-Ad (P>0.05 for treatment difference). Both treatments were well tolerated. Conclusion: SYSB lubricant eye drops were non-inferior to RFO-Ad for improvement in TFBUT in patients with lipid-deficient dry eye. Both lubricant eye drops improved TFBUT and ocular discomfort scores in patients with lipid-deficient dry eye.
引用
收藏
页码:1665 / 1673
页数:9
相关论文
共 50 条
  • [21] A Decade of Effective Dry Eye Disease Management with Systane Ultra (Polyethylene Glycol/Propylene Glycol with Hydroxypropyl Guar) Lubricant Eye Drops
    Srinivasan, Sruthi
    Manoj, Venkiteshwar
    CLINICAL OPHTHALMOLOGY, 2021, 15 : 2421 - 2435
  • [22] Comparison between homologous serum eye drops and platelet-rich plasma eye drops as treatment for dry eye disease
    Passilongo, Mattia
    Bergamo, Loretta
    Romanelli, Federica
    Lovisi, Andrea
    Colosio, Maura
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [23] Lipid layer thickness changes following the instillation of two novel lubricant eye drops
    Korb, DR
    Scaffidi, RC
    Greiner, JV
    Kenyon, KR
    Herman, JP
    Blackie, CA
    Glonek, T
    Case, CL
    Finnemore, M
    Douglass, T
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [24] Efficacy and Safety of Phospholipid Nanoemulsion-Based Ocular Lubricant for the Management of Various Subtypes of Dry Eye Disease: A Phase IV, Multicenter Trial
    Yeu, Elizabeth
    Silverstein, Steven
    Guillon, Michel
    Schulze, Marc-Matthias
    Galarreta, David
    Srinivasan, Sruthi
    Manoj, Venkiteshwar
    CLINICAL OPHTHALMOLOGY, 2020, 14 : 2561 - 2570
  • [25] Evaluation of clinical outcomes in patients with dry eye disease using lubricant eye drops containing polyethylene glycol or carboxymethylcellulose
    Cohen, Stephen
    Martin, Anna
    Sall, Kenneth
    CLINICAL OPHTHALMOLOGY, 2014, 8 : 157 - 164
  • [26] Randomized, Multicenter, Double–Blind Study of the Safety and Efficacy of 1%D-3-Hydroxybutyrate eye drops for Dry Eye Disease
    Tetsuya Kawakita
    Miki Uchino
    Kazumi Fukagawa
    Kenichi Yoshino
    Seika Shimazaki
    Ikuko Toda
    Mari Tanaka
    Hiroyuki Arai
    Keiko Sakatani
    Seiichiro Hata
    Takashi Okano
    Kazuo Tsubota
    Scientific Reports, 6
  • [27] Efficacy of topical cyclosporine 0.05% and osmoprotective lubricating eye drops in treating dry eye disease and inflammation
    Mullick, Ritika
    Annavajjhala, Sriram
    Thakur, Prashansa
    Mohapatra, Ayushi
    Shetty, Rohit
    D'Souza, Sharon
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2021, 69 (12) : 3473 - 3477
  • [28] Semi-fluorinated Mane Eye Drops Reduce Signs and Symptoms of Evaporative Dry Eye Disease After Cataract Surgery
    Son, Hyeck-Soo
    Yildirim, Timur M.
    Khoramnia, Ramin
    Poompokawat, Piyanut
    Knorz, Michael C.
    Auffarth, Gerd U.
    JOURNAL OF REFRACTIVE SURGERY, 2020, 36 (07) : 474 - +
  • [29] Comparison of the efficacy and safety of two eye gels in the treatment of dry eyes: Lacrinorm and Viscotears
    Bron, AJ
    Daubas, P
    Siou-Mermet, R
    Trinquand, C
    EYE, 1998, 12 (5) : 839 - 847
  • [30] Comparison of the efficacy and safety of two eye gels in the treatment of dry eyes: Lacrinorm and Viscotears
    A J Bron
    P Daubas
    R Siou-Mermet
    C Trinquand
    Eye, 1998, 12 : 839 - 847